A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the superiority regarding vitreomacular adhesion
(VMA) resolution of a single intravitreal injection of A01016 (Ocriplasmin) compared to
sham-injection in subjects with symptomatic VMA.